Changing Characteristics and Mode of Death Associated With Chronic Heart Failure Caused by Left Ventricular Systolic Dysfunction
- 1 July 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation: Heart Failure
- Vol. 4 (4), 396-403
- https://doi.org/10.1161/circheartfailure.110.959882
Abstract
Therapies for patients with chronic heart failure caused by left ventricular systolic dysfunction have advanced substantially over recent decades. The cumulative effect of these therapies on mortality, mode of death, symptoms, and clinical characteristics has yet to be defined. This study was a comparison of 2 prospective cohort studies of outpatients with chronic heart failure caused by left ventricular systolic dysfunction performed between 1993 and 1995 (historic cohort: n=281) and 2006 and 2009 (contemporary cohort: n=357). In the historic cohort, 83% were prescribed angiotensin-converting enzyme inhibitors and 8.5% were prescribed β-adrenoceptor antagonists, compared with 89% and 80%, respectively, in the contemporary cohort. Mortality rates over the first year of follow-up declined from 12.5% to 7.8% between eras ( P =0.04), and sudden death contributed less to contemporary mortality (33.6% versus 12.7%; P P P <0.001). Survival has significantly improved in patients with chronic heart failure caused by left ventricular systolic dysfunction over the past 15 years; furthermore, sudden death makes a much smaller contribution to mortality, and noncardiac mortality is a correspondingly greater contribution. This has been accompanied by an improvement in symptoms and some markers of adverse electric and structural left ventricular remodeling.Keywords
This publication has 40 references indexed in Scilit:
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in AdultsCirculation, 2009
- Long-Term Trends in First Hospitalization for Heart Failure and Subsequent Survival Between 1986 and 2003Circulation, 2009
- Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysisBMJ, 2007
- Significance of QRS Complex Duration in Patients With Heart FailureJournal of the American College of Cardiology, 2005
- Usefulness of spatial dispersion of QRS duration in predicting mortality in patients with mild to moderate chronic heart failureThe American Journal of Cardiology, 2004
- Trends in Heart Failure Incidence and Survival in a Community-Based PopulationJAMA, 2004
- QT Dispersion Has No Prognostic Value in Patients with Symptomatic Heart Failure: An ELITE II SubstudyPacing and Clinical Electrophysiology, 2003
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effects of Early Treatment, Lead Time and Length Bias on the Mortality Experienced by Cases Detected by ScreeningInternational Journal of Epidemiology, 1982